These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 32247026)
21. Methodological tools and sensitivity analysis for assessing quality or risk of bias used in systematic reviews published in the high-impact anesthesiology journals. Marušić MF; Fidahić M; Cepeha CM; Farcaș LG; Tseke A; Puljak L BMC Med Res Methodol; 2020 May; 20(1):121. PubMed ID: 32423382 [TBL] [Abstract][Full Text] [Related]
22. Comparison of methodological quality rating of systematic reviews on neuropathic pain using AMSTAR and R-AMSTAR. Dosenovic S; Jelicic Kadic A; Vucic K; Markovina N; Pieper D; Puljak L BMC Med Res Methodol; 2018 May; 18(1):37. PubMed ID: 29739339 [TBL] [Abstract][Full Text] [Related]
23. There were large discrepancies in risk of bias tool judgments when a randomized controlled trial appeared in more than one systematic review. Jordan VM; Lensen SF; Farquhar CM J Clin Epidemiol; 2017 Jan; 81():72-76. PubMed ID: 27622779 [TBL] [Abstract][Full Text] [Related]
25. Methodological quality and risk of bias in orthodontic systematic reviews using AMSTAR and ROBIS. Hooper EJ; Pandis N; Cobourne MT; Seehra J Eur J Orthod; 2021 Oct; 43(5):544-550. PubMed ID: 33723612 [TBL] [Abstract][Full Text] [Related]
26. The effect of the CONSORT statement on the amount of "unclear" Risk of Bias reporting in Cochrane Systematic Reviews. Rademaker MM; Ramakers GGJ; Smit AL; Hooft L; Stegeman I PLoS One; 2020; 15(7):e0235535. PubMed ID: 32650340 [TBL] [Abstract][Full Text] [Related]
27. Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews. Kabir A; Sofi-Mahmudi A; Karimi Behnagh A; Eidkhani V; Baradaran HR; Kabiri P; Haghdoost A; Mesgarpour B Arch Iran Med; 2022 Jun; 25(6):375-382. PubMed ID: 35943017 [TBL] [Abstract][Full Text] [Related]
28. Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials. Armijo-Olivo S; Ospina M; da Costa BR; Egger M; Saltaji H; Fuentes J; Ha C; Cummings GG PLoS One; 2014; 9(5):e96920. PubMed ID: 24824199 [TBL] [Abstract][Full Text] [Related]
29. Risk of bias assessments and reporting quality of systematic reviews and randomized controlled trials examining acupuncture for depression: An overview and meta-epidemiology study. Luo S; Long Y; Xiao W; Wang X; Chen R; Guo Q; Liu J; Shao R; Du L; Chen M J Evid Based Med; 2020 Feb; 13(1):25-33. PubMed ID: 32112515 [TBL] [Abstract][Full Text] [Related]
30. Are Neonatal Trials Better Conducted and Reported over the Last 6 Decades? An Analysis on Their Risk-of-Bias Status in Cochrane Reviews. Lai NM; Ong JMJ; Chen KH; Chaiyakunapruk N; Ovelman C; Soll R Neonatology; 2019; 116(2):123-131. PubMed ID: 31108494 [TBL] [Abstract][Full Text] [Related]
31. Appraisal of systematic reviews on the management of peri-implant diseases with two methodological tools. Faggion CM; Monje A; Wasiak J J Clin Periodontol; 2018 Jun; 45(6):754-766. PubMed ID: 29575189 [TBL] [Abstract][Full Text] [Related]
32. Risk of bias tool in systematic reviews/meta-analyses of acupuncture in Chinese journals. Liu Y; Yang S; Dai J; Xu Y; Zhang R; Jiang H; Yan X; Yang K PLoS One; 2011; 6(12):e28130. PubMed ID: 22174772 [TBL] [Abstract][Full Text] [Related]
33. [Application of the Risk of Bias 2 Tool]. Lee LL Hu Li Za Zhi; 2021 Apr; 68(2):85-91. PubMed ID: 33792022 [TBL] [Abstract][Full Text] [Related]
34. Methodological quality and risk-of-bias assessments in systematic reviews of treatments for peri-implantitis. Hasuike A; Ueno D; Nagashima H; Kubota T; Tsukune N; Watanabe N; Sato S J Periodontal Res; 2019 Aug; 54(4):374-387. PubMed ID: 30671962 [TBL] [Abstract][Full Text] [Related]
35. Quality Assessment of Studies Included in Cochrane Oral Health Systematic Reviews: A Meta-Research. Sofi-Mahmudi A; Iranparvar P; Shakiba M; Shamsoddin E; Mohammad-Rahimi H; Naseri S; Motie P; Tovani-Palone MR; Mesgarpour B Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299733 [TBL] [Abstract][Full Text] [Related]
36. Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool. Bilandzic A; Fitzpatrick T; Rosella L; Henry D PLoS Med; 2016 Apr; 13(4):e1001987. PubMed ID: 27046153 [TBL] [Abstract][Full Text] [Related]
37. Intra-articular hyaluronic acid injection in treating knee osteoarthritis: assessing risk of bias in systematic reviews with ROBIS tool. Xing D; Wang B; Zhang W; Yang Z; Hou Y; Chen Y; Lin J Int J Rheum Dis; 2017 Nov; 20(11):1658-1673. PubMed ID: 29044993 [TBL] [Abstract][Full Text] [Related]
38. Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane. Flemyng E; Moore TH; Boutron I; Higgins JP; Hróbjartsson A; Nejstgaard CH; Dwan K BMJ Evid Based Med; 2023 Aug; 28(4):260-266. PubMed ID: 36693715 [TBL] [Abstract][Full Text] [Related]
39. Common challenges and suggestions for risk of bias tool development: a systematic review of methodological studies. Tomlinson E; Cooper C; Davenport C; Rutjes AWS; Leeflang M; Mallett S; Whiting P J Clin Epidemiol; 2024 Jul; 171():111370. PubMed ID: 38670243 [TBL] [Abstract][Full Text] [Related]
40. Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews. Yao Y; Shen J; Luo J; Li N; Liao X; Zhang Y Trials; 2024 Jun; 25(1):405. PubMed ID: 38907276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]